Nebula Research & Development LLC Elanco Animal Health Inc Transaction History
Nebula Research & Development LLC
- $1.08 Trillion
- Q1 2025
A detailed history of Nebula Research & Development LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 34,835 shares of ELAN stock, worth $580,699. This represents 0.03% of its overall portfolio holdings.
Number of Shares
34,835
Previous 162,027
78.5%
Holding current value
$580,699
Previous $1.96 Billion
81.36%
% of portfolio
0.03%
Previous 0.23%
Shares
5 transactions
Others Institutions Holding ELAN
# of Institutions
420Shares Held
451MCall Options Held
753KPut Options Held
671K-
Dodge & Cox San Francisco, CA82.9MShares$1.38 Billion0.53% of portfolio
-
Primecap Management CO Pasadena, CA50.2MShares$837 Million0.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.3MShares$806 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$388 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A622MShares$367 Million11.21% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $7.9B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...